Roberto Rittner Selected Research

4- ((3- bromophenyl)amino)- 6,7- dimethoxyquinazoline

5/2010	Potent cardioprotective effect of the 4-anilinoquinazoline derivative PD153035: involvement of mitochondrial K(ATP) channel activation.
12/2009	EGFR tyrosine kinase inhibitor (PD153035) improves glucose tolerance and insulin action in high-fat diet-fed mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roberto Rittner Research Topics

Disease

2	Inflammation (Inflammations) 01/2016 - 12/2009
1	Glioma (Gliomas) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Acne Vulgaris 05/2011
1	Breast Neoplasms (Breast Cancer) 09/2010
1	Ischemia 05/2010
1	Insulin Resistance 12/2009

Drug/Important Bio-Agent (IBA)

2	Phosphotransferases (Kinase)IBA 09/2010 - 12/2009
2	4- ((3- bromophenyl)amino)- 6,7- dimethoxyquinazolineIBA 05/2010 - 12/2009
1	Growth Factor ReceptorsIBA 01/2021
1	Neuropilin-1IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Scorpion Venoms (Scorpion Venom)IBA 01/2021
1	GuanineIBA 01/2016
1	SolventsIBA 05/2011
1	anilinoquinazolineIBA 05/2010
1	Cyanides (Isocyanides)IBA 05/2010
1	Insulin Receptor Substrate ProteinsIBA 12/2009
1	Pharmaceutical PreparationsIBA 12/2009
1	Nonesterified Fatty Acids (NEFA)IBA 12/2009
1	Glucose (Dextrose)FDA LinkGeneric 12/2009
1	Insulin (Novolin)FDA Link 12/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2009
1	Interleukin-6 (Interleukin 6)IBA 12/2009
1	NF-kappa B (NF-kB)IBA 12/2009